Tilg H - Search Results

1

Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, Golenbock D, Gresnigt MS, Heneka MT, Hoffman HM, Hotchkiss R, Joosten LAB, Kastner DL, Korte M, Latz E, Libby P, Mandrup-Poulsen T, Mantovani A, Mills KHG, Nowak KL, O'Neill LA, Pickkers P, van der Poll T, Ridker PM, Schalkwijk J, Schwartz DA, Siegmund B, Steer CJ, Tilg H, van der Meer JWM, van de Veerdonk FL, Dinarello CA. Netea MG, et al. Among authors: tilg h. Nat Immunol. 2017 Jul 19;18(8):826-831. doi: 10.1038/ni.3790. Nat Immunol. 2017. PMID: 28722720 Free PMC article.

2

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.

Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Tilg H, et al. J Exp Med. 1993 Nov 1;178(5):1629-36. doi: 10.1084/jem.178.5.1629. J Exp Med. 1993. PMID: 7693853 Free PMC article.

3

Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans.

Tilg H, Vogel W, Dinarello CA. Tilg H, et al. Blood. 1995 Jan 15;85(2):433-5. Blood. 1995. PMID: 7811997 Free article.

4

Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.

Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinarello CA. Tilg H, et al. Hepatology. 1993 Nov;18(5):1132-8. Hepatology. 1993. PMID: 8225219

5

Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.

Tilg H, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. J Immunol. 1993 Sep 15;151(6):3299-307. J Immunol. 1993. PMID: 8397255

6

Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy.

Tilg H, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Cytokine. 1995 Oct;7(7):734-9. doi: 10.1006/cyto.1995.0087. Cytokine. 1995. PMID: 8580384 Clinical Trial.

7

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators.

Tilg H, Dinarello CA, Mier JW. Tilg H, et al. Immunol Today. 1997 Sep;18(9):428-32. doi: 10.1016/s0167-5699(97)01103-1. Immunol Today. 1997. PMID: 9293158 Review.

8

Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.

Kaser A, Novick D, Rubinstein M, Siegmund B, Enrich B, Koch RO, Vogel W, Kim SH, Dinarello CA, Tilg H. Kaser A, et al. Among authors: tilg h. Clin Exp Immunol. 2002 Aug;129(2):332-8. doi: 10.1046/j.1365-2249.2002.01911.x. Clin Exp Immunol. 2002. PMID: 12165091 Free PMC article.

9

Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.

Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Vogel W, Tilg H. Ludwiczek O, et al. Among authors: tilg h. J Clin Immunol. 2002 Nov;22(6):331-7. doi: 10.1023/a:1020600230977. J Clin Immunol. 2002. PMID: 12462332

10

Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.

Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H. Ludwiczek O, et al. Among authors: tilg h. Clin Exp Immunol. 2004 Nov;138(2):323-9. doi: 10.1111/j.1365-2249.2004.02599.x. Clin Exp Immunol. 2004. PMID: 15498044 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

506 results

Search Page